Injections, Intramuscular
Conditions
Interventions
This is a randomized, controlled, factorial and open clinical study. Experimental Group 1 will consist of 42 children who will wear the Buzzy device positioned for 15 seconds before the intramuscular
Sponsors
Programa de Pós-Graduação em Enfermagem da Universidade Federal de Santa Catarina
Hospital Infantil Joana de Gusmão da Secretaria de Estado da Saúde de Santa Catarina
Eligibility
Age
1 Years to 11 Years
Inclusion criteria
Inclusion criteria: To be in the age range of 1 to 11 years, 11 months, and 29 days old. Have a medical prescription for intramuscular injection
Exclusion criteria
Exclusion criteria: Child with Raynaud's disease or other vasospastic disorders. Hypersensitivity to cold. Cardiac disorders with impairment of local circulation. Rheumatoid disease. Hypertensive disease. Anesthetized skin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess pain associated with intramuscular injection in children. It is expected to find scores of no pain or mild pain associated with intramuscular injection in children. Verified in children aged 1 to 3 years, 11 months and 29 days by the researcher using the Face, Legs, Activity, Cry, Consolability Scale and in children aged between 4 and 11 years, 11 months and 29 days through self-report, researcher assessment and responsible using the Faces Pain Scale Revised | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate behavior associated with intramuscular injection in children. The child is expected to display collaborative behaviors during the intramuscular injection. Verified by the researcher using variables from the Observation Scale of Behavior Distress | — |
Countries
Brazil
Contacts
Public ContactJefferson Moura
Universidade Federal de Santa Catarina
Outcome results
None listed